359 related articles for article (PubMed ID: 15953990)
21. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
[TBL] [Abstract][Full Text] [Related]
22. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
24. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
26. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis.
Li JJ; Fang CH; Jiang H; Huang CX; Hui RT; Chen MZ
Clin Chim Acta; 2004 Dec; 350(1-2):115-21. PubMed ID: 15530467
[TBL] [Abstract][Full Text] [Related]
27. Effects of tirofiban on acute systemic inflammatory response in elective percutaneous coronary interventions.
Akbulut M; Ozbay Y; Gundogdu O; Dagli N; Durukan P; Ilkay E; Arslan N
Curr Med Res Opin; 2004 Nov; 20(11):1759-67. PubMed ID: 15537476
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
Alfonso F; Melgares R; Mainar V; Lezaún R; Vázquez N; Tascón J; Pomar F; Cequier A; Angel J; Pérez-Vizcayno MJ; Sabaté M; Bañuelos C; Fernández C; García JM;
Eur Heart J; 2004 Oct; 25(20):1829-35. PubMed ID: 15474698
[TBL] [Abstract][Full Text] [Related]
29. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions.
Yazdani S; Simon AD; Vidhun R; Gulotta C; Schwartz A; Rabbani LE
Am Heart J; 1998 Aug; 136(2):357-61. PubMed ID: 9704702
[TBL] [Abstract][Full Text] [Related]
31. Is inflammation a contributor for coronary stent restenosis?
Li JJ; Nie SP; Zhang CY; Gao Z; Zheng X; Guo YL
Med Hypotheses; 2007; 68(5):945-51. PubMed ID: 17045418
[TBL] [Abstract][Full Text] [Related]
32. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
33. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
[TBL] [Abstract][Full Text] [Related]
34. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
[TBL] [Abstract][Full Text] [Related]
35. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention.
Patti G; Pasceri V; Carminati P; D'Ambrosio A; Carcagnì A; Di Sciascio G
Am J Cardiol; 2005 Feb; 95(4):502-5. PubMed ID: 15695139
[TBL] [Abstract][Full Text] [Related]
36. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
[TBL] [Abstract][Full Text] [Related]
38. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
Chyrchel M; Dudek D; Bartuś S; Legutko J; Heba G; Dubiel JS
Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
[TBL] [Abstract][Full Text] [Related]
39. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
[TBL] [Abstract][Full Text] [Related]
40. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
